Celyad SA Top Management

CYADDelisted Stock  USD 0.52  0.00  0.00%   
Celyad SA employs about 35 people. The company is managed by 8 executives with a total tenure of roughly 82 years, averaging almost 10.0 years of service per executive, having 4.38 employees per reported executive. Evaluation of Celyad SA's management performance can provide insight into the firm performance.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Celyad SA Management Team Effectiveness

The company has return on total asset (ROA) of (0.2541) % which means that it has lost $0.2541 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7072) %, meaning that it created substantial loss on money invested by shareholders. Celyad SA's management efficiency ratios could be used to measure how well Celyad SA manages its routine affairs as well as how well it operates its assets and liabilities.

Celyad SA Workforce Comparison

Celyad SA is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 496. Celyad SA holds roughly 35.0 in number of employees claiming about 7% of equities under Health Care industry.

Celyad SA Notable Stakeholders

A Celyad SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Celyad SA often face trade-offs trying to please all of them. Celyad SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Celyad SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Celyad SA Management Performance

The success or failure of an entity such as Celyad SA often depends on how effective the management is. Celyad SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Celyad management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Celyad management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T cell therapies for the treatment of cancer. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. Celyad Sa operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.
Please note, the presentation of Celyad SA's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Celyad SA's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Celyad SA's management manipulating its earnings.

Celyad SA Workforce Analysis

Traditionally, organizations such as Celyad SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Celyad SA within its industry.

Celyad SA Manpower Efficiency

Return on Celyad SA Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.2M
Net Loss Per Executive5.1M
Working Capital Per Employee125.7K
Working Capital Per Executive549.9K
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Consideration for investing in Celyad Stock

If you are still planning to invest in Celyad SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Celyad SA's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges